Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 45:1707-1715, doi:10.1016/j.jacc.2005.02.046
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, X.
Right arrow Articles by Yue, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, X.
Right arrow Articles by Yue, H.

Cyclooxygenase-1 Mediates the Final Stage of Morphine-Induced Delayed Cardioprotection in Concert With Cyclooxygenase-2

Xiaojing Jiang, MD*, Enyi Shi, MD, PhD{dagger}, Yoshiki Nakajima, MD, PhD*, Shigehito Sato, MD*,*, Koji Ohno, PhD{ddagger} and Hui Yue, MD*

* Department of Anesthesiology, Hamamatsu University School of Medicine, Hamamatsu, Japan
{dagger} First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
{ddagger} Department of Anatomy and Neuroscience, Hamamatsu University School of Medicine, Hamamatsu, Japan.



View larger version (27K):

[in a new window]
 
Figure 1 Experimental groups and protocol. IN = indomethacin; IP = intraperitoneal; M = morphine; NS = NS-398; SC = SC-560.

 


View larger version (19K):

[in a new window]
 
Figure 2 Measurement of myocardial region at risk in all experimental groups. The region at risk is expressed as a percentage of the weight of left ventricle. Open circles represent individual mice, whereas solid circles represent mean ± SEM. There was no significant difference among the 13 groups. IN = indomethacin; M = morphine; NS = NS-398; SC = SC-560.

 


View larger version (21K):

[in a new window]
 
Figure 3 Measurement of myocardial infarct size in all experimental groups. The infarct size is expressed as a percentage of the region at risk. Open circles represent individual mice, whereas solid circles represent mean ± SEM. IN = indomethacin; IP = intraperitoneal; M = morphine; NS = NS-398; SC = SC-560.

 


View larger version (22K):

[in a new window]
 
Figure 4 Myocardial content of prostaglandin (PG)E2 and 6-keto-PGF1-alpha after morphine (M) pretreatment. Data are mean ± SEM. IN = indomethacin; NS = NS-398; SC = SC-560. *p < 0.05 vs. control; {dagger}p < 0.05 vs. M 48 h; {ddagger}p < 0.05 vs. M 24 h.

 


View larger version (23K):

[in a new window]
 
Figure 5 Expression of cyclooxygenase (COX)-2 in the membranous fraction of myocardium. (A) Representative Western blots illustrating COX-2 expression. (B) Densitometric quantification of COX-2 protein expressed as a percentage of the average value of control mice. Data are mean ± SEM. M = morphine. *p < 0.05 vs. control.

 


View larger version (25K):

[in a new window]
 
Figure 6 Expression of cyclooxygenase (COX)-1 in the membranous fraction of myocardium. (A) Representative Western blots showing COX-1 expression. (B) Densitometric quantification of COX-1 protein expressed as a percentage of the average value of control mice. Data are mean ± SEM. M = morphine. *p < 0.05 vs. control.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement